Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and modafinil

3,4-dihydroxyphenylacetic acid has been researched along with modafinil in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Agnati, LF; Finnman, UB; Fuxe, K; Goldstein, M; Janson, AM; Morari, M; Rosén, L; Tanganelli, S1
Colla, M; Endres, M; Gertz, K; Hellmann-Regen, J; Kronenberg, G; Uhlemann, R1
Danysz, W; Flik, G; Hauber, W; Russ, H; Sommer, S; Valastro, B1
Belliard, S; Berrebi-Bertrand, I; Finance, O; Giret, M; Krief, S; Lecomte, JM; Ligneau, X; Nagmar, I; Perrin, D; Robert, P; Schwartz, JC; Uguen, M1

Other Studies

4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and modafinil

ArticleYear
Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Experimental brain research, 1992, Volume: 88, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Anesthesia, General; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Immunohistochemistry; Kinetics; Male; Mice; Mice, Inbred C57BL; Modafinil; MPTP Poisoning; Nerve Degeneration; Neurons; Reference Values; Substantia Nigra; Tyrosine 3-Monooxygenase

1992
Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells.
    European archives of psychiatry and clinical neuroscience, 2012, Volume: 262, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antineoplastic Agents; Benzhydryl Compounds; Cell Differentiation; Cell Line, Tumor; Cytochrome P-450 CYP3A; Dopamine; Erythromycin; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Mice; Modafinil; Neuroblastoma; Neurofilament Proteins; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Protein Synthesis Inhibitors; Transfection; Tretinoin

2012
The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Choice Behavior; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methylphenidate; Modafinil; Motivation; Neuropsychological Tests; Rats, Sprague-Dawley; Reinforcement Schedule

2014
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corpus Striatum; Disorders of Excessive Somnolence; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Drug Inverse Agonism; Feeding Behavior; Histamine Antagonists; Locomotion; Mice; Modafinil; Narcolepsy; Neostriatum; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Phenylalanine; Piperidines; Receptors, Histamine H3; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents

2021